ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression

<p>The drug treatments we use to manage atrial fibrillation don't change the progression in the disease.</p> <p>Catheter ablation, even when performed in younger and healthier patients, modifies the disease trajectory and prevents progression.</p> <p>In this interview, Jason G. Andrade MD, FRCPC and Christopher M. Kramer MD, FACC discuss AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression.</p> <p><a href= "https://itunes.apple.com/us/podcast/eagles-eye-view-your-weekly-cv-update-from-acc-org/id1274635046"> Subscribe on Apple</a> Podcasts | <a href= "https://play.google.com/music/listen#/ps/I6dtkumvaipematzgzmbph2koiq"> Subscribe on Google Play</a> | <a href= "http://www.acc.org/education-and-meetings/products-and-resources/accel-audio"> Subscribe to ACCEL</a></p>